Non-interventional study

Non-interventional study

Retrospective, non-interventional multicenter study on the effect of QUVIVIQ in patients with insomnia disorder with comorbid anxiety and/or depression disorders

Germany

Italy

Spain

United Kingdom

EU PAS number:

EUPAS1000000594

First published:

27/06/2025

Last updated 27/06/2025

StudyPlanned

Real-world post-authorization effectiveness study (PAES) of pembrolizumab for the treatment of NSCLC across races, ethnicities, and age groups (MK-3475-G18)

United States

EU PAS number:

EUPAS1000000576

First published:

03/06/2025

Last updated 12/06/2025

StudyPlanned

Patient outcomes and clinical characteristics of ATTR-CM patients treated with tafamidis: A single center experience in Turkey - Study ATTREAL

Türkiye

EU PAS number:

EUPAS1000000561

First published:

01/07/2025

Last updated 01/07/2025

StudyPlanned

Real-life data study of the French cohort of patients with Rendu Osler disease treatment with bevacizumab:the CoBevaRO study.

France

EU PAS number:

EUPAS1000000548

First published:

11/04/2025

Last updated 06/05/2025

StudyOngoing

Real-world effectiveness of pembrolizumab among patients with TMB-H advanced solid tumors (MK-3475-G34)

United States

EU PAS number:

EUPAS1000000542

First published:

06/05/2025

Last updated 06/05/2025

StudyOngoing

Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)

United States

EU PAS number:

EUPAS1000000441

First published:

21/02/2025

Last updated 06/05/2025

StudyOngoing

AN ITALIAN RETROSPECTIVE-PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF ZANUBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (AZALEA)

Italy

EU PAS number:

EUPAS1000000437

First published:

20/02/2025

Last updated 10/03/2025

StudyOngoing

Pergoveris patients’ profile and outcome response measurement in IVF/ICSI autologous cycles (PERFORM)

France

Germany

Greece

Italy

Norway

Romania

Spain

Switzerland

EU PAS number:

EUPAS1000000435

First published:

20/01/2025

Last updated 20/01/2025

StudyOngoing

Paternal exposure to valproate and the risk of neurodevelopmental disorders in children

Norway

Taiwan

EU PAS number:

EUPAS1000000417

First published:

14/04/2025

Last updated 14/04/2025

StudyOngoing

Characterize infections and outcomes developed in relapsed/refractory multiple myeloma (RRMM) patients treated with Teclistamab (SPOT)

Portugal

EU PAS number:

EUPAS1000000414

First published:

16/01/2025

Last updated 04/07/2025

StudyOngoing